Trials / Recruiting
RecruitingNCT07320040
Evaluation of Emotion-related Salivary Molecular Biomarkers
Evaluation of Emotion-related Salivary Molecular Biomarkers Following Olfactory Stimuli
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Sys2Diag · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Recent studies show that emotional states can be discriminated by physiological responses. This physiological regulation results from the action of enzymes and hormones that represent the activity of the autonomic nervous system. The measurement of specific biomarkers, using non-invasive biological tests in saliva, would therefore provide physiological data on an individual's emotional state in response to stimuli, particularly olfactory stimuli.
Detailed description
Recent studies show that emotional states (positive and negative) can be discriminated by physiological responses. This physiological regulation stems from the action of enzymes and hormones that represent the activity of the autonomic nervous system. The measurement of specific biomarkers (enzymes, hormones), using non-invasive biological tests in saliva, would therefore provide physiological data on an individual's emotional state (Giacomello et al. 2020) in response to stimuli, particularly olfactory stimuli. The aim of the proposed research is to identify and measure a signature of molecular biomarkers in saliva, linked to emotions following one or more olfactory stimuli (e.g. cortisol and alpha-amylase concentration increase after stimulation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Identication and measurement of a molecular biomarkers signature | Levels of the biomarkers of interest (DHEA, pg/mL; Oxytocin, pg/mL; Cortisol, pg/mL; Alpha Amylase, U/mL) will be measured in the saliva of participating subjects by enzymatic assay methods or ELISA-type methods performed using commercial kits. |
Timeline
- Start date
- 2022-11-14
- Primary completion
- 2023-03-14
- Completion
- 2027-06-14
- First posted
- 2026-01-06
- Last updated
- 2026-01-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07320040. Inclusion in this directory is not an endorsement.